lyophilized powder raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
Clinical research typically uses randomised, double-blind, placebo-controlled designs. The most common primary endpoint is the desire domain score of the Female Sexual Function Index, sometimes paired with a distress measure. Secondary outcomes include arousal, satisfaction, and event-based counts of satisfying sexual episodes. Across trials, average improvements are modest and individual responses vary widely. Whether benefits persist beyond a few months, and whether they depend on baseline hormone status, remain open questions rather than settled findings.
Melanocortin receptors form a family of five G-protein-coupled receptors designated MC1 through MC5. Bremelanotide binds most strongly at MC4R and MC1R, with weaker activity reported at MC3R and MC5R. MC4R is expressed in hypothalamic nuclei that coordinate energy balance and aspects of sexual behaviour. The prevailing interpretation is that central MC4R activation, rather than peripheral vascular effects alone, drives the reported changes in desire. This account remains partly inferential, since direct receptor-level measurement in living humans is not practical.
After subcutaneous administration, plasma concentrations rise within roughly thirty minutes and the elimination half-life is short, on the order of two to three hours. Reported physiological responses include transient increases in blood pressure and nausea, which tended to diminish with repeated dosing in trial settings. Because the peptide clears quickly, effects are not expected to persist long after a dose. Absorption from non-injected routes is poorly characterised, and nasal delivery produced variable plasma levels in older work.
Handling procedures emphasize minimizing moisture uptake, since the dried solid is hygroscopic and can draw water when warmed to room temperature before a vial is opened. Laboratories record lot number, purity, counter-ion content, and residual solvent data supplied by the producer. Impurity profiles are compared run to run, and any shift in retention time or peak shape prompts re-verification against a reference standard. Certificates of analysis are treated as claims to be checked rather than accepted at face value.
Identity and purity testing for this peptide typically relies on reversed-phase high-performance liquid chromatography with ultraviolet detection, reported as area-percent purity. Mass spectrometry, usually in tandem mode, confirms molecular mass and supports quantification in biological matrices. Sequence confirmation may use peptide mapping after enzymatic digestion, while nuclear magnetic resonance and circular dichroism supply supplementary structural detail. No single technique establishes identity alone, so laboratories compare retention time, mass, and fragment pattern against a verified reference standard.
| Property | Value | Notes |
|---|---|---|
| Primary receptor targets | MC4R and MC1R | Agonist activity; MC3R and MC5R weaker |
| Route studied in trials | Subcutaneous injection | Intranasal form was not approved |
| Elimination half-life | Approximately 2–3 hours | Short relative to the dosing interval |
| Common analytical method | Liquid chromatography–tandem mass spectrometry | Used for peptide quantification in plasma |
| Reported adverse events | Nausea, flushing, headache | Transient blood pressure rise also noted |
Bremelanotide acts as a non-selective agonist at melanocortin receptors, with reported activity at MC1R, MC3R, MC4R and MC5R. The proposed basis for its central effects is activation of MC4R populations in the hypothalamus, a region associated with appetite and reproductive signalling. Because the peptide carries a net positive charge and polar side chains, it does not cross biological membranes freely, which is one reason oral administration is not the standard route. Effects generally appear within an hour of parenteral administration and are described as centrally mediated rather than peripheral.
Bremelanotide, developed under the code PT-141, is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone. Its structure is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, with a lactam bridge joining the aspartate and lysine side chains. The molecule has the formula C50H68N14O10 and a monoisotopic mass near 1025 daltons. It is commonly prepared as the acetate salt and appears as a white to off-white lyophilised powder in solid form. The free acid is the pharmacologically relevant species, while the counter-ion improves handling and dissolution.
Early research on PT-141 grew out of work on melanotan II, a related cyclic peptide studied for pigmentation. Investigators observed that centrally acting melanocortin agonists also influenced sexual behaviour in animal models, and the programme shifted toward that endpoint. A nasal formulation was evaluated in clinical trials but showed inconsistent absorption, and later studies used subcutaneous administration instead. Regulatory approval in the United States followed in 2019 for a defined population of premenopausal women with acquired, generalised hypoactive sexual desire disorder. That approval was specific to that group rather than a broad indication.
Bremelanotide is a moderately large peptide with a molecular mass near 1025 daltons. In lyophilised form it appears as a white to off-white powder and is freely soluble in water and other polar solvents. The intact lactam ring is essential for receptor affinity, while linearised fragments bind far more weakly. Solutions are sensitive to extremes of pH and to prolonged exposure to light and heat, so handling typically involves buffered conditions and cold storage. Its short plasma half-life reflects rapid distribution and clearance rather than chemical breakdown inside the vial.
Development of the peptide passed through several delivery formats, including an intranasal version tested in early trials and an injectable version that entered later clinical study. Regulatory approval for a subcutaneous product in the United States was granted in 2019 after review of controlled trials in premenopausal women. Outside the clinic, the compound circulates in research and non-pharmaceutical markets under its code name, where identity and purity vary considerably between suppliers. Synonyms appearing across technical literature include bremelanotide, PT-141, and Palatin 141.
PT-141 is the research designation for bremelanotide, a synthetic cyclic heptapeptide developed as a melanocortin receptor agonist. The peptide contains seven amino acids with an internal lactam bridge that constrains the backbone into a stable ring. Cyclisation of this kind improves resistance to enzymatic degradation relative to linear analogues. The compound was first explored for effects on melanin production, because several melanocortin receptors influence pigmentation. Its later association with sexual desire emerged from observations made during that early work, and the molecule became the subject of a separate development programme.
Claimed benefits of using probiotic supplements are not supported by sufficient clinical evidence. Meta-analysis studies have reported a modest reduction of antibiotic-associated diarrhea and acute diarrhea in children taking probiotics. There is limited evidence in support of adults using mono-strain and multi-strain containing probiotics for the alleviation of symptoms associated with irritable bowel syndrome. Probiotic supplements are generally regarded as safe.
North Branch, Minnesota: Specialty Press, 2010. ISBN 978-1-58007-152-9. O'Leary, Michael. USAAF Fighters of World War Two. New York: Sterling Publishing Co., 1986. ISBN 0-7137-1839-0. Oliver, David. P-51 Mustang. Amberley Publishing, 2023. ISBN 9781398110564. Olmsted, Merle. The 357th Over Europe: the 357th Fighter Group in World War II. St. Paul, Minnesota: Phalanx Publishing, 1994. ISBN 0-933424-73-6. Pace, Steve. "Mustang – Thoroughbred Stallion of the Air". Stroud, UK: Fonthill Media, 2012. ISBN 978-1-78155-051-9 Pearcy, Arthur. Lend-Lease Aircraft in World War II. Shrewsbury, UK: Airlife Publishing Ltd., 1996. ISBN 1-85310-443-4. "Pentagon Over the Islands: The Thirty-Year History of Indonesian Military Aviation". Air Enthusiast Quarterly (2): 154–162. n.d. ISSN 0143-5450. Sgarlato, Nico. "Mustang P-51" (in Italian). I Grandi Aerei Storici (Monograph series) N.7, November 2003. Parma, Italy: Delta Editrice. ISSN 1720-0636. Shores, Christopher. "The Allison-engined Mustang: A Fighting Combination". Air Enthusiast Quarterly, No. 2, n.d., pp. 191–206. ISSN 0143-5450 Sims, Edward H. Fighter Tactics and Strategy 1914–1970. Fallbrook, California: Aero publisher Inc., 1980. ISBN 0-8168-8795-0. Smith, J. Richard, Eddie J. Creek and Peter Petrick. On Special Missions: The Luftwaffe's Research and Experimental Squadrons 1923–1945 (Air War Classics). Hersham, Surrey, UK: Classic Publications, 2004. ISBN 1-903223-33-4. Spick, Mike. Fighter Pilot Tactics. The Techniques of Daylight Air Combat. Cambridge, UK: Patrick Stephens, 1983. ISBN 0-85059-617-3. Spick, Mike.
== Successor == A successor mod, Firearms: Source, was created by a different development team for the Source engine. It was released on July 23, 2010. The initial release included eight maps, five game modes, and 31 weapons. Giochi per il mio computer gave the mod a rating of two out of five.
== Symptoms == Polycythemia is often asymptomatic; patients may not experience any notable symptoms until their red cell count is very high. For patients with significant elevations in hemoglobin or hematocrit (often from polycythemia vera), some non-specific symptoms include:
=== Medication === Overall, pharmaceuticals have limited benefit for treating anorexia. However, olanzapine, an antipsychotic, has been shown to result in a modest but statistically significant increase in body weight in AN patients, in addition to a decrease in obsessive thoughts. While the effectiveness of antidepressants in treating anorexia has not been well established, fluoxetine, an SSRI, can also be used during treatment. Metreleptin is undergoing research for its potential benefit in the treatment of anorexia nervosa. It is hypothesized that the gradual loss of body fat mass, and the ensuing low leptin levels, influence the psychological components of the disorder. It was shown that short-term metreleptin treatment of patients with anorexia nervosa had rapid on-set of beneficial cognitive, emotional, and behavioral effects. Among other things, depression, drive for activity, repetitive thoughts of food, inner restlessness, and weight phobia decreased rapidly. Whether metreleptin (or another leptin analogue) is a suitable treatment for anorexia nervosa remains to be seen.
Sources: en.wikipedia.org
== Hospitals == People's Hospital of Ningxia Hospital of Traditional Chinese Medicine of Ningxia Ningxia Medical College Affiliated Hospital Yinchuan Hospital of Traditional Chinese Medicine Yinchuan People's Hospital Yinchuan Stomatological Hospital Yinchuan Women and Children's Healthcare Center Women and Children's Healthcare Center of Ningixa Yinchuan No.1 People's Hospital Yinchuan No.2 People's Hospital Yinchuan No.3 People's Hospital Shizuishan No.2 People's Hospital Guyuan Hospital of Ningxia
== External links == Mercaptans (or Thiols) at The Periodic Table of Videos (University of Nottingham) Applications, Properties, and Synthesis of ω-Functionalized n-Alkanethiols and Disulfides – the Building Blocks of Self-Assembled Monolayers by D. Witt, R. Klajn, P. Barski, B.A. Grzybowski at Northwestern University. Mercaptan, by The Columbia Electronic Encyclopedia What is Mercaptan? Archived 2008-12-20 at the Wayback Machine, by Columbia Gas of Pennsylvania and Maryland. What Is the Worst Smelling Chemical? Archived 2011-06-06 at the Wayback Machine, by About Chemistry.
Prokaryotic ubiquitin-like protein (Pup) is a functional analog of ubiquitin which has been found in the gram-positive bacterial phylum Actinomycetota. It serves the same function (targeting proteins for degradations), although the enzymology of ubiquitylation and pupylation is different, and the two families share no homology. In contrast to the three-step reaction of ubiquitylation, pupylation requires two steps, therefore only two enzymes are involved in pupylation. In 2017, homologs of Pup were reported in five phyla of gram-negative bacteria, in seven candidate bacterial phyla and in one archaeon The sequences of the Pup homologs are very different from the sequences of Pup in gram-positive bacteria and were termed Ubiquitin bacterial (UBact), although the distinction has yet not been proven to be phylogenetically supported by a separate evolutionary origin and is without experimental evidence. The finding of the Pup/UBact-proteasome system in both gram-positive and gram-negative bacteria suggests that either the Pup/UBact-proteasome system evolved in bacteria prior to the split into gram positive and negative clades over 3000 million years ago or, that these systems were acquired by different bacterial lineages through horizontal gene transfer(s) from a third, yet unknown, organism. In support of the second possibility, two UBact loci were found in the genome of an uncultured anaerobic methanotrophic Archaeon (ANME-1;locus CBH38808.1 and locus CBH39258.1).
Latent antithrombin on formation immediately links to a molecule of native antithrombin to form the heterodimer, and it is not until the concentration of latent antithrombin exceeds 50% of the total antithrombin that it can be detected analytically. Not only is the latent form of antithrombin inactive against its target coagulation proteases, but its dimerisation with an otherwise active native antithrombin molecule also results in the native molecules inactivation. The physiological impact of the loss of antithrombin activity either through latent antithrombin formation or through subsequent dimer formation is exacerbated by the preference for dimerisation to occur between heparin activated β-antithrombin and latent antithrombin as opposed to α-antithrombin. A form of antithrombin that is an intermediate in the conversion between native and latent forms of antithrombin has also been isolated and this has been termed prelatent antithrombin.
Joy Osmanski as Paula Brooks / Tigress (season 3; recurring season 1; guest season 2):A member of the ISA who hunts the world's most dangerous humans. She is a gym teacher at Blue Valley High, the wife of "Crusher" Crock, and mother of Artemis Crock. In the second season, she breaks out of prison twice. In the third and final season, she moves in next door to the Whitmore-Dugans. Joel McHale as Sylvester Pemberton / Starman and Gerard Shugel / Ultra-Humanite (season 3; guest season 1; recurring season 2):A member of the original JSA who used an anti gravity Cosmic Staff invented by scientist Ted Knight that Courtney later finds. In the present, Ultra-Humanite forms an alliance with Icicle and Dragon King before transplanting his brain into Sylvester Pemberton's body in order to manipulate Stargirl and her JSA, and Dragon King's brain into Ultra-Humanite's albino gorilla body for him to "defeat" as Starman alongside Jordan's son before intending to run for president as a mouthpiece for Icicle to spread his ideals.
Sources: en.wikipedia.org
== Notes == ^α Three countries - Mauritius, Saint Lucia, and Saudi Arabia - have not had figures reported by the FAO since the 1990s but are still included in the data; all three continue to produce coffee at a small scale. They are counted here as producing nations but not included in the global totals. ^β Values for China are estimated by the ICO.
Scared, they decide to escape by pushing a weirdly unstable brick, which causes another to crush on Ren; Stimpy assists him after getting out. They run as quickly as they can, only to stumble on a policeman, who almost decides to send them to the dog pound again until Ren reveals his address. They return to see Granny dead from lead poisoning; it is implied that Mr. Hao killed her, as a lead pipe is dropped while he speaks and he embodies everyone, including a goldfish, in Granny's will except for the duo, who are instead euthanized, freeze dried and used as statues in the residence alongside Granny. Mr. Hao goes off to enjoy his newfound wealth after dusting the statues, ending the episode.
Nanoghosts are nanosized vesicles containing a chosen drug delivery payload manufactured from extracted leukocyte membranes with the cell cytoplasm content removed. The use of biological membranes serves to mask the particles from the immune system to reduce the likelihood of an immunogenic response, as well as to extend circulation of the particles in the blood. They are produced by homogenizing the cells to remove the cytosol, and then sonicating the empty cell membranes to create nanoghosts between 100 and 200 nm in diameter. Membranes used to make nanoghosts harvested form red blood cells have been shown to circulate for about 120 days and avoid phagocytotic cells. Neutrophil based nanoghosts retain the chemotaxis capacity of neutrophils to sites of inflammation, which encourages tumor targeting. NK based nanoghosts exhibit metastatic cancer targeting behavior. Monocyte based nanoghosts are effective at infiltrating the tumor microenvironment. Mesenchymal stem cell derived nanoghosts exhibit cancer targeting properties.
In February of 2025 the first case of CRISPR gene editing therapy on a child was documented. It was used to treat Severe Carbamoyl Phosphate Synthetase 1 Deficiency. It was administered At Children's Hospital of Philadelphia and is currently successful in its use to counteract the disease. "Advanced Gene Editing: CRISPR-Cas9" (PDF). Congressional Research Service. Archived from the original (PDF) on 5 December 2017. Retrieved 24 October 2017. "Jennifer Doudna talk: Genome Engineering with CRISPR-Cas9: Birth of a Breakthrough Technology". 10 September 2022. Archived from the original on 25 November 2016. Retrieved 24 November 2016. "Human Nature". NOVA. Season 47. Episode 9. 9 September 2020. PBS. WGBH. Retrieved 7 April 2023.
Sources: en.wikipedia.org
Trial results generally show a small to moderate average improvement in desire scores relative to placebo. The distribution of responses is wide, and some participants show little measurable change. Group averages should not be read as a prediction for any single person.
Nausea, flushing, headache, and transient blood pressure elevation are the most frequently reported events. These typically appear shortly after dosing and are usually described as mild to moderate in severity. Safety data covering long periods of continuous use remain limited.
A short half-life means the compound clears from circulation within hours, so any effect is tied closely to dosing time. Accumulation between doses is therefore unlikely under the studied schedule. The practical consequence is that timing of administration shapes what observers record.
Chemical degradation such as hydrolysis and oxidation proceeds more slowly as temperature falls. Cold storage also limits microbial growth in reconstituted material. Repeated warming should be avoided because thermal cycling stresses the peptide.